Last updated: June 19, 2022
Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bulimia
Pain (Pediatric)
Cancer
Treatment
N/AClinical Study ID
NCT05344820
ARQULA
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18 years or older
- Conscious and no communication problems
- Being literate
- Having a cancer diagnosis
- Receiving chemotherapy treatment (planned to continue treatment for 8 more weeks)
- Willing to participate in our study voluntarily
Exclusion
Exclusion Criteria:
- Not being willing to participate in the research
- Desire to leave the study at any time
- Deterioration of compliance with the working criteria during the time of the study,
- Those who do not participate in up to four mandala applications during the studyperiod
- Those who cannot use a pen
- Those with a diagnosis of psychiatric and neurological disease
- Patients who are scheduled for drug intervention, radiotherapy, surgery other thanchemotherapy within 8 weeks
Study Design
Total Participants: 90
Study Start date:
May 19, 2022
Estimated Completion Date:
December 31, 2022
Study Description
Connect with a study center
Sultan Abdülhamid Training and Research Hospital
Üsküdar, İstanbul 34660
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.